Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Why Inspection Readiness Is Becoming Harder; Digital GMP Raises New Risks

In a recent interview with Christopher Cole of Pharmaceutical Technology, Henrik Johanning from Epista Life Science discussed how pharmaceutical manufacturing and regulatory systems in Europe are shifting from 2025 into 2026. He explained that quality risk management, digital GMP, and
  • News
Why Inspection Readiness Is Becoming Harder; Digital GMP Raises New Risks

SOP Checklist in 2026: Red Flags Found During GMP Audits

This article explains how SOP Checklist failures influence GMP inspection outcomes and how structured compliance systems improve audit readiness. It highlights real inspection patterns, document control gaps, and practical strategies to strengthen pharmaceutical quality system performance.
  • Blog, Quality Management System
GMP inspection readiness checklist in pharmaceutical laboratory showing SOP compliance pharma workflow, document control, and audit preparation under quality system standards.

Pharmaceutical Audits in 2026: GMP Audit Checklist and Findings

Explore how pharmaceutical internal audits and GMP audit checklist practices enhance inspection readiness, strengthen pharmaceutical quality system compliance, and reduce recurring audit findings. Learn how data integrity controls and structured audit processes support effective regulatory audit performance.
  • Blog, Quality Management System
GMP internal audit pharma process showing pharmaceutical audit checklist GMP execution, data integrity audit trail pharma verification, and inspection readiness assessment within a pharmaceutical quality system.